Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Donald C Goff

Showing results (31-40 of 207) with videos related to

Pageof 21
Sort By:
The Journal of Clinical Psychiatry|April 30, 2011
Treatment adherence in schizophrenia and schizoaffective disorderDonald C Goff, Michele Hill, Oliver Freudenreich
Journal of Clinical Psychopharmacology|January 8, 2004
Clozapine-induced sialorrhea treated with sublingual ipratropium spray: a case seriesOliver Freudenreich, Martha Beebe, Donald C Goff
The Journal of Clinical Psychiatry|December 31, 2010
Strategies for improving treatment adherence in schizophrenia and schizoaffective disorderDonald C Goff, Michele Hill, Oliver Freudenreich
Pharmacology, Biochemistry, and Behavior|December 1, 2010
The treatment of cognitive impairment in schizophreniaDonald C Goff, Michele Hill, Deanna Barch
The American Journal of Psychiatry|November 1, 2023
Another Step Toward the Prediction of Antipsychotic Treatment Response Using Functional ConnectivityDonald C Goff, Joshua Roffman, Daphne J Holt
Expert Review of Neurotherapeutics|July 6, 2007
Inflammation and schizophreniaXiaoduo Fan, Donald C Goff, David C Henderson
Early Intervention in Psychiatry|March 1, 2011
Initial medical work-up of first-episode psychosis: a conceptual reviewOliver Freudenreich, S Charles Schulz, Donald C Goff
Current Drug Targets. CNS and Neurological Disorders|May 29, 2003
Ionotropic glutamate receptors as therapeutic targets in schizophreniaJoseph T Coyle, Guochuan Tsai, Donald C Goff
Psychopharmacology|July 8, 2005
The potential role of lamotrigine in schizophreniaCharles H Large, Elizabeth L Webster, Donald C Goff
Journal of Clinical Psychopharmacology|January 12, 2005
Adverse cardiac effects associated with clozapineDavid B Merrill, G William Dec, Donald C Goff
Pageof 21

Showing results (31-40 of 207) with videos related to

Sort By:
Pageof 21
The Journal of Clinical Psychiatry|April 30, 2011
Treatment adherence in schizophrenia and schizoaffective disorderDonald C Goff, Michele Hill, Oliver Freudenreich
Journal of Clinical Psychopharmacology|January 8, 2004
Clozapine-induced sialorrhea treated with sublingual ipratropium spray: a case seriesOliver Freudenreich, Martha Beebe, Donald C Goff
The Journal of Clinical Psychiatry|December 31, 2010
Strategies for improving treatment adherence in schizophrenia and schizoaffective disorderDonald C Goff, Michele Hill, Oliver Freudenreich
Pharmacology, Biochemistry, and Behavior|December 1, 2010
The treatment of cognitive impairment in schizophreniaDonald C Goff, Michele Hill, Deanna Barch
The American Journal of Psychiatry|November 1, 2023
Another Step Toward the Prediction of Antipsychotic Treatment Response Using Functional ConnectivityDonald C Goff, Joshua Roffman, Daphne J Holt
Expert Review of Neurotherapeutics|July 6, 2007
Inflammation and schizophreniaXiaoduo Fan, Donald C Goff, David C Henderson
Early Intervention in Psychiatry|March 1, 2011
Initial medical work-up of first-episode psychosis: a conceptual reviewOliver Freudenreich, S Charles Schulz, Donald C Goff
Current Drug Targets. CNS and Neurological Disorders|May 29, 2003
Ionotropic glutamate receptors as therapeutic targets in schizophreniaJoseph T Coyle, Guochuan Tsai, Donald C Goff
Psychopharmacology|July 8, 2005
The potential role of lamotrigine in schizophreniaCharles H Large, Elizabeth L Webster, Donald C Goff
Journal of Clinical Psychopharmacology|January 12, 2005
Adverse cardiac effects associated with clozapineDavid B Merrill, G William Dec, Donald C Goff
Pageof 21